Doxazosin ratiopharm 4 mg tablets

Doxazosin ratiopharm is a generic pharmaceutical product used primarily for treating hypertension and symptoms of benign prostatic hyperplasia. The brand 'ratiopharm' was originally established as a pioneer in the German generic drug market, emphasizing affordable healthcare. Its original parent company was Merckle GmbH.

In 2010, ratiopharm was acquired by Teva Pharmaceutical Industries Ltd., the world's largest generic drug manufacturer. While the ratiopharm brand maintains its historical identity, particularly in European markets like Germany and Italy, it is now part of Teva's global supply chain. Consequently, manufacturing occurs in various specialized facilities across Europe and Israel, depending on the specific formulation and regional distribution requirements. The ultimate ownership lies with Teva, headquartered in Tel Aviv, Israel.